PROSPECT MEDICAL PRACTICE — All Prescriptions & Medications — Page 6
Practice Code: D82087 | NORWICH, NR3 2HW
Showing results 251-300 of 484
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Hypromellose | 57 | 1,210 | £270 | -57.0% ▼ |
| Dabigatran etexilate | 56 | 2,520 | £2.1K | +8.2% ▲ |
| Zonisamide | 55 | 4,060 | £2.0K | +26.1% ▲ |
| Testosterone | 55 | 1,469 | £957 | -27.9% ▼ |
| Hydrocortisone acetate | 55 | 1,740 | £332 | -16.7% ▼ |
| Pravastatin sodium | 53 | 1,764 | £76 | -83.7% ▼ |
| Lymecycline | 53 | 2,142 | £246 | -55.9% ▼ |
| Dexamethasone | 53 | 896 | £719 | -11.2% ▼ |
| Benzoyl peroxide and clindamycin phosphate | 53 | 2,340 | £979 | -20.9% ▼ |
| Coal tar | 53 | 12.8K | £263 | -27.2% ▼ |
| Alverine citrate | 52 | 5,096 | £226 | +25.7% ▲ |
| Nitrazepam | 52 | 728 | £43 | +0.1% vs avg |
| Co-beneldopa (Benserazide/levodopa) | 52 | 9,500 | £564 | -65.6% ▼ |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 51 | 2,030 | £151 | +26.9% ▲ |
| Tranexamic acid | 50 | 2,968 | £193 | -41.0% ▼ |
| Phenytoin sodium | 50 | 2,912 | £364 | -38.1% ▼ |
| Alfacalcidol | 49 | 1,560 | £209 | -60.4% ▼ |
| Neomycin sulfate | 49 | 735 | £93 | -17.3% ▼ |
| Sulfasalazine | 48 | 6,328 | £1.1K | -63.1% ▼ |
| 48 | 4,248 | £263 | -77.8% ▼ | |
| Theophylline | 47 | 2,801 | £1.4K | -43.8% ▼ |
| Ready to serve 1.5 kcal/ml milkshake (0913011) | 47 | 408.8K | £2.3K | -66.9% ▼ |
| 47 | 69 | £8.6K | +31.6% ▲ | |
| Rabeprazole sodium | 46 | 2,164 | £231 | -10.8% ▼ |
| Orlistat | 46 | 4,032 | £951 | -44.2% ▼ |
| Tibolone | 46 | 1,603 | £147 | +50.3% ▲ |
| 46 | 335 | £273 | +320.2% ▲ | |
| Bezafibrate | 45 | 1,448 | £344 | -16.5% ▼ |
| Ready to serve 2.4 kcal/ml milkshake lower volume (0913011) | 45 | 332.5K | £4.5K | -63.7% ▼ |
| Benzydamine hydrochloride | 45 | 8,700 | £147 | -41.8% ▼ |
| Hepatitis A | 45 | 45 | £883 | -40.7% ▼ |
| Tadalafil | 44 | 196 | £42 | -74.1% ▼ |
| Fenofibrate | 43 | 1,424 | £171 | -55.6% ▼ |
| Nortriptyline | 43 | 2,558 | £231 | -70.4% ▼ |
| 43 | 366 | £328 | +38.1% ▲ | |
| 43 | 8,070 | £14.4K | -11.8% ▼ | |
| Sitagliptin | 42 | 1,113 | £60 | -89.2% ▼ |
| Magnesium glycerophosphate | 42 | 7,545 | £3.8K | +205.7% ▲ |
| Zinc sulfate | 42 | 294 | £61 | +241.1% ▲ |
| Typhoid | 42 | 42 | £432 | -53.4% ▼ |
| 42 | 19.4K | £151 | -53.9% ▼ | |
| Enalapril maleate | 41 | 2,016 | £134 | -77.2% ▼ |
| Dutasteride | 40 | 1,350 | £81 | -22.1% ▼ |
| Letrozole | 40 | 1,120 | £101 | -78.6% ▼ |
| Glipizide | 39 | 4,928 | £211 | +227.2% ▲ |
| Verapamil hydrochloride | 38 | 1,568 | £286 | -58.1% ▼ |
| Ciprofloxacin | 38 | 980 | £73 | -4.7% ▼ |
| Alfuzosin hydrochloride | 38 | 1,380 | £525 | -46.9% ▼ |
| Metoclopramide hydrochloride | 37 | 1,629 | £52 | -55.3% ▼ |
| Hydrocortisone | 37 | 2,882 | £191 | -56.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.